Conclusion. There is increasing interest in research on cannabis. The research only partially reflects the drug's importance with regard to number of users.
In the USA, a law passed in 1944 legally banned research on cannabis for medical purposes. This law was based on a committee report by the then New York mayor, Fiorello LaGuardia, 4 in which he stated that cannabis consumption leads to tolerance, resulting in a need for a higher dose to achieve the same effect. The law was introduced by Harry J Anslinger from the Federal Bureau of Narcotics and was amended in 1962 after his retirement. 5 The discussion of cannabis legalisation continues today. A recent event was the passing of the first marijuana decriminalisation law on 4 November 2008 in Massachusetts, USA, which reduced the legal consequences of possession of small amounts of cannabis. 6 Cannabis is significant not only in terms of the conflict that rages over its legal status, but also because of its widespread use and the resulting legal and medical costs. Cannabis is estimated to be the world's third most popular recreational drug, following alcohol and tobacco, with an estimated 160 million people (4% of the world's population) using cannabis annually. 7 This widespread use is particularly worrying in the light of data that have established cannabis use as a non-genetic risk factor
Background. Cannabis has been a topic of political and medical controversy in many countries over the past century.
Although many publications on this topic are available, there is currently no comprehensive evaluation of global research activities in the field.
Objective. This study was conducted in order to provide a quantitative and qualitative analysis of the worldwide research output on cannabis. The various aspects of cannabis have been described in numerous publications over the years. These aspects have never been scientometrically examined. The objective of this study was therefore to analyse trends in cannabis research from 1900 to 2008 in terms of publication date, countries of origin, main topics, and main research areas of the 10 most published authors. We were also interested in comparing cannabis with other harmful substances (alcohol, tobacco, cocaine and heroin) with regard to the number of publications relative to the number of respective users.
Methods

Data source
The data for this project were retrieved from the Web of Science (ISI-Web) database of the Thomson Institute for Scientific Information.
16,17
Search strategies
The phrase 'cannabis*' was used in order to find all scientific publications that address cannabis. The asterisk was added to root words to include stem words with all possible endings. As a comparison, a similar search was conducted using the words 'alcohol*', 'tobacco*', 'cocaine*' and 'heroin*'.
Time span
The 
Citation measures
The 'citation report' function was used to analyse the published 
Density-equalising mapping
In this method, specific calculations based on Gastner and
Newman's algorithm 18 were used in order to produce a map of the world, in which the different countries were resized according to specific variables -in this case, according to the total cannabis publications from each country. 
Analysis of publication content
Origin
One-quarter of the 6 376 items published between 1900 and 2008 originated from researchers in the USA, 14% from the UK, 8% from Australia and 6% from Germany. Table I presents the 20 most prolific countries. Using density-equalising mapping, a rescaled map of the world was created to depict the number of publications per country (Fig. 3) .
As a measure of the quality of the publications from the different countries, we used the average citation rate and compared the countries that have published at least 30 papers. We found Using density-equalising mapping, a rescaled map of the world was created to depict the average citation rates of the countries with at least 30 publications (Fig. 4) . To establish the extent of co-operation between countries, a radar chart graph was used to depict the partnered countries and quantity of collectively published items (Fig. 5) . Twenty-five countries co-operated in publishing at least five papers with other countries. The countries that co-operated most frequently with other countries were the USA, the UK, Germany, Canada and the Netherlands. The two countries with the highest share of collaborative publications were the Netherlands and Germany.
Thirty-one per cent of Dutch and 25% of German cannabis publications were the result of international collaboration. The fraction of co-operative articles for the two most prolific countries (USA and UK) was 17%.
Subject area analysis
To investigate the various subject areas in which papers on cannabis were published, the top five subject areas in the field of cannabis from 1999 to 2008 were compared in terms of their respective percentages over the past four decades (Fig. 6) .
Of 
Analysis of content of publications
To (Table II) .
Discussion
This paper describes the findings of a scientometric analysis of all available publications on the subject of cannabis published between 1900 and 2008. We found increases in publication numbers during the 1960s and a major rise since the 1990s. We also analysed the number of publications on cannabis compared with alcohol, tobacco, cocaine and heroin. The latter three substances showed some discrepancies in publication numbers cannabis use was widespread. 22 The increase in publications since 1990 has also been shown in other research fields such as psoriasis 23 and rheumatoid arthritis. 24 This increase has been attributed to the boost in scientific exchange resulting from better means of electronic communication since the 1990s. 26 A change in the exploration algorithm that the ISI database implemented in the 1990s might also have contributed to the steep rise. 25 In 1963, de Sola Price published a theory claiming that scientific output will double every 10 -15 years. 27 We found that publications on cannabis increased by 15 times from 1990 to 2006, a much bigger increase than suggested by Future analysis will shed more light on developments over time.
We also compared the countries that published most papers with the average citation rates, as a measure of the quality of the publications. We found that Italy, Sweden and Israel had higher average citation rates than the countries that published most papers, i.e. the USA, the UK and Australia. This could indicate that the countries with high average citation rates published more general papers, which had a higher impact and were therefore read by more people. Lower average citation rates could be due to more subject-specific publications, which were read by less people and therefore cited less.
With regard to co-operation between countries, we found that countries with high output in other research fields, such as the USA, the UK, Germany, Canada and the Netherlands, often co-operated with each other and with other countries. 23 In analysing the contents of the publications, we took two different approaches. First an overall impression was obtained by looking at the subject areas of the publications. We found that the areas of psychiatry, neuroscience and clinical neurology increased in importance over time, accounting for more than 50% of the publications compared with those in other subject areas over the past decade. This increase could be attributed to the negative side-effects of cannabis, especially psychoses and mental health problems in young people. 36 The increases in publications in clinical neurology and the neurosciences might be due to the therapeutic uses of cannabis in neurological conditions such as chronic pain, multiple sclerosis, nausea caused by chemotherapy, and loss of appetite in AIDS patients. 8, 9 In a second approach, we analysed the main topics of the publications of the 10 authors with most publications. We found that the most prolific authors were interested in the pharmacological contents of the cannabis plant and the effects of cannabis use, especially dependency, psychosis and depression. 4, 8, 9, 12, 13 These themes also reflect the two sides of cannabis use as they are generally perceived: concern about the plant's effects, especially with regard to the young age of users 36 and major psychiatric conditions 10 that are harmful to both the individual and society, and the hope placed on the plant's potential use in alleviating certain medical conditions.
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